Cite
MLA Citation
F. Child et al.. “Phase II multicentre trial of oral quisinostat, a histone deacetylase inhibitor, in patients with previously treated stage IB–IVA mycosis fungoides/Sézary syndrome.” British journal of dermatology, vol. 175, 2016, pp. 80–88. http://access.bl.uk/ark:/81055/vdc_100172212092.0x00003a